Lyka Labs Limited

Lyka Labs Limited

Share · INE933A01014 (XBOM)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Lyka Labs Limited
No Price
Closing Price XBOM 29.04.2026: 61,39 INR
29.04.2026 09:55
Current Prices from Lyka Labs Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XNSE: NSE
NSE
LYKALABS.NS
INR
29.04.2026 09:55
60,38 INR
0,33 INR
+0,55 %
XBOM: MSE
MSE
LYKALABS.BO
INR
29.04.2026 09:51
61,39 INR
1,34 INR
+2,23 %
Share Float & Liquidity
Free Float 83,97 %
Shares Float 29,97 M
Shares Outstanding 35,69 M
Company Profile for Lyka Labs Limited Share
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. Lyka Labs Limited was incorporated in 1976 and is based in Mumbai, India.

Company Data

Name Lyka Labs Limited
Company Lyka Labs Limited
Website https://www.lykalabs.com
Primary Exchange XBOM MSE
ISIN INE933A01014
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Kunal Narendra Gandhi
Market Capitalization 2 Mrd.
Country India
Currency INR
Employees 0,4 T
Address Spencer Building, 400036 Mumbai
IPO Date 2001-12-05
Dividends from 'Lyka Labs Limited'
Ex-Date Dividend per Share
12.08.1996 2,50 INR
11.09.1995 2,50 INR

Ticker Symbols

Name Symbol
MSE LYKALABS.BO
NSE LYKALABS.NS
More Shares
Investors who hold Lyka Labs Limited also have the following shares in their portfolio:
MASTER DRILLING GROUP LTD
MASTER DRILLING GROUP LTD Share
PERFORMANCE ONE AG
PERFORMANCE ONE AG Share